Efficacy of azithromycin combined with compounded atovaquone in treating babesiosis in giant pandas
Authors:
Open Access
- 23 December 2024
- journal article
- research article
- Published by Springer Nature in Parasites & Vectors
- Vol. 17 (1) , 1-14
Abstract
Background: Babesia is a tick-borne protozoan blood parasite that can cause hemolytic anemia, thrombocytopenia, lethargy and splenomegaly in giant pandas. Methods: We evaluated the efficacy and safety profile of a therapeutic regimen combining atovaquone and zithromycin in the context of babesiosis in giant pandas that have been naturally infected. The examined pandas underwent clinical and laboratory analyses, including hematology, biochemistry and thyroid hormone profiles. Upon diagnosis, the giant pandas were administered a compounded treatment consisting of atovaquone oral suspension (15 mg/kg, PO, q8 h), azithromycin tablets (10 mg/kg, PO, q24 h) and Enteral Nutritional Suspension (TPF) as a fat-rich supplement (0.5 ml/kg, PO, q8 h) for a 10-day period. Results: The combination treatment increased the red blood cell count, hemoglobin levels and hematocrit in the pandas within a short period, while also reducing parasite levels below the PCR detection threshold. Conclusions: Our study suggested that atovaquone and azithromycin combination therapy is highly effective for emergency treatment of Babesia sp. infection in giant pandas. GraphicalKeywords
Funding Information
- National Natural Science Foundation of China (32400405, U21A20193)
- Chengdu Giant Panda Breeding Research Foundation (2024CPB-A23)
- Sichuan Provincial Science and Technology Support Program (2023NSFSC1156)
- Chengdu Municipal Science and Technology Program (2023-YF09-00017-SN)
This publication has 66 references indexed in Scilit:
- Elevation of free triiodothyronine (fT3) levels by Plasmodium falciparum independent of thyroid stimulating hormone (TSH) in children with uncomplicated malariaJournal of Clinical Laboratory Analysis, 2024
- Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosisBiomedicine & Pharmacotherapy, 2023
- Human BabesiosisInfectious Disease Clinics of North America, 2022
- Severe babesiosis due to Babesia divergens acquired in the United KingdomAmerican Journal of Hematology, 2021
- Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug developmentLife Sciences, 2016
- Microbial Metabolism of Atovaquone and Cytotoxicity of the Produced Phase I MetaboliteEuropean Journal of Drug Metabolism and Pharmacokinetics, 2015
- A retrospective serological survey on human babesiosis in BelgiumClinical Microbiology and Infection, 2015
- Canine BabesiosisVeterinary Clinics of North America: Small Animal Practice, 2010
- The pituitary-thyroid axis in severe falciparum malaria: evidence for depressed thyrotroph and thyroid gland functionTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Human BabesiosisJAMA, 1982